Delivery Order SPE2DB24D3015-SPE2DB25FFZYK

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a ceiling value of $6,729.39, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sandimmune 25 mg capsules, a pharmaceutical product, with a period of performance through May 19, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.69 firm fixed-price delivery order is for the supply of 4559601786 SANDIMMUNE 25 MG CAPSULE UD 30S and has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,477.70, is a Firm Fixed Price Delivery Order for the supply of Sandimmune 25 mg capsules. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SANDIMMUNE 25 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $3,278.34 and a performance period through May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Sandimmune 25 mg capsules. The contract, valued at $3,182.85, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a $16,589.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 14, 2025 and was not set aside for any specific business category. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $36,118.74 with a firm fixed-price pricing type and an ultimate completion date of January 28, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that was previously awarded to Amerisourcebergen by the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $17,863.71, and has an ultimate completion date of July 1, 2025. The contract covers the supply of pharmaceutical products, medical devices, and other healthcare-related supplies to support military and government healthcare...
This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,486.08 and an Ultimate Completion Date of May 28, 2025. The contract provides for the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of pharmaceutical products, valued at $1,811.35, with a performance period ending on June 13, 2025. The contract is a firm fixed-price, non-set-aside vehicle, allowing for open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZYK
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $16,240.15 and a completion date of June 30, 2025. The contract is for the supply of SANDIMMUNE 25 MG CAPSULE UD 30S, a pharmaceutical product.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described is not set-aside and was open to competition.

Generated 9/26/25, 9:50 AM